Showing only trials that are North East England

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

Testing a new treatment to understand it’s efficacy and the best dose for patients

Expected to end: 31/03/2028

A study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma

An early phase study of the efficacy and safety of a new drug

Expected to end: 08/01/2026

Oxford Pre-cancerous Lymphoproliferative Disorders Study (OxPLoreD)

Looking for markers that might predict disease is progressing

Expected to end: 01/10/2025